In the present study, we evaluated the CRMP2 phosphorylation state in postmortem brain tissues from AD patients and non-AD individuals, in brain lysates, and in cultured cortical neurons from the double transgenic APP/PS1 mice and their wild-type (WT) littermates. This evidence concerns the gene APP and Alzheimer disease.